Medical Invention Consulting is a private firm providing Medical Technology assessment, commercialization, and investment services. Medical Invention Consulting specializes in evaluating clinical utility, form factor, and market potential of medical inventions. Clients have included:
Academic Institutions / Medical Device Start-Ups / Corporations - Assessing whether new medical technology should be patented and/or commercialized; efficacy of technology; need for the technology, market size, IP quality protection, clinical trial need / design / quality
Medical Device Inventors - Giving advice regarding protection and commercialization of their ideas; ownership, market size, competition assessment, prototyping, clinical trial design, royalty / sale negotiation
Medical Device Investors - Conducting due diligence on medical device investment opportunities; quality of the technology, product demand, market size, IP quality, clinical trial quality, competition assessment, business plan review, past / projected financials
Lloyd Marks, MD, MBA, FACC, Principal at Medical Invention Consulting, is an MIT trained Electrical Engineer, Johns Hopkins trained Pediatric Cardiologist, and Inventor. Always active in both medicine and medical engineering, Dr. Marks has been granted 22 Medical Device Patents.
Background Experience - Dr. Marks was in academic medicine for 15 years, as the Director of the Cardiac Cath Lab at St. Christopher's Hospital for Children and the Division Chief of Pediatric Cardiology at the Children's Hospital of New Jersey. He was then in private practice for 18 years. In 1997 he opened his clinical practice, specializing in Pediatric and Adult Congenital Heart Disease, where he provided clinical evaluation, electrocardiography, echocardiography, stress testing, Holter/event monitoring, diagnostic cardiac catheterization, and interventional cardiac catheterization.
After closing his clinical practice in 2015, Dr. Marks went to business school and obtained an MBA from the Haslam School of Business, University of Tennessee. While there, he wrote a business plan with financial projections for his startup company, MGI Medical, LLC, commercializing a non-invasive patient monitor for the detection of post-operative bleeding. Dr. Marks has successfully licensed 9 of his inventions to industry and assigned 8 to MGI.
Anthony C Chang, MD, MBA, MPH, MS is internationally recognized as an expert in the field of Pediatric Cardiology. He has a master’s degree in Healthcare Administration from University of Miami School of Business, from which he graduated with the McGaw Prize for academic excellence and a master's degree in Biomedical Data Science from Stanford University. Dr. Chang also has a master’s degree in Public Health from UCLA, from which he graduated with the Dean’s Award for academic excellence.
Dr. Chang leads pediatric heart teams all over the world. He was one of the founding members of the Asia-Pacific Pediatric Cardiac Society (APPCS) and will be initiating the foundation arm of the society at the bequest of the board. A world-renown leader in pediatric cardiology innovation, Dr. Chang is a member of the grant review committee for pediatric research at the National Institutes of Health. Respected in his field, he is a member the board of directors for the American Heart Association.
Providing leadership in education, Dr. Chang has served with the faculty of UCLA School of Public Health (eMPH program) and has taught global health for UCLA’s eMPH. He also teaches pediatric cardiology to cardiology fellows and holds a volunteer faculty appointment at the UCLA School of Medicine.
Doctor Chang - Being A Doctor
Dr. Chang is the founder of the Pediatric Cardiac Intensive Care Society (PCICS) that launched the multi-disciplinary focus on cardiac intensive care for children. He is also the founder of the Asia-Pacific Pediatric Cardiac Society (APPCS), which united pediatric cardiologists and cardiac surgeons from 24 Asian countries and launched a biennial meeting in Asia that now draws over 1,000 attendees. Dr. Chang has made over 50 medical missions around the world, including over 25 trips to China.
Dr. Chang is the founder and medical director of the Medical Intelligence and Innovation Institute (MI3), dedicated to implementing data science and artificial intelligence in medicine and is the first institute of its kind in a hospital. Dr. Chang is the organizing chair of several Artificial Intelligence in Medicine (AIMed) meetings in the U.S. and abroad that will focus on artificial intelligence in healthcare and medicine. He intends to build a clinician-computer scientist interface to enhance all aspects of data science and artificial intelligence in health and medicine.
A prolific author, Dr. Chang is the chief editor of the textbook Pediatric Cardiac Intensive Care and the past president-elect of the Pediatric Cardiac Intensive Care Society (PCICS). He is the chief editor of the textbook Heart Failure in Children and Young Adults. He is a regular reviewer for “Circulation,” “Pediatric Critical Care Medicine,” “Critical Care Medicine,” and numerous other journals.
Dr. Chang publishes and lectures widely on topics of big data and artificial intelligence in medicine, pediatric cardiac intensive care, heart failure, sudden cardiac death, adult congenital heart disease, and other aspects of congenital heart disease. He has served as program director for numerous large international conferences and symposia.
The technological singularity described by futurist Ray Kurzweil is the phenomenon when technology supercedes the human intellect . The current ascent to singularity is at an exponential rate (Law of Accelerating Returns) due mainly to escalating computing power (Moore's Law), and is estimated to occur by the year 2045 or sooner.
This is an academic dividend of the popular Pediatric Cardiology Review biannual course that was started by Dr. Chang and Dr. Eidem. The book contains over 875 questions & answers and is geared toward pediatric cardiologists taking the boards or maintenance of certification, pediatricians, and cardiologists interested in freshening their skills. It provides hundreds of questions relating to the diagnosis and treatment of the fetus, infant, child, and adult with congenital heart diseases.
This unique resource provides today's state-of-the-art guidance on the diagnosis and treatment of heart failure in children and adolescents. Contributions from the fields of surgery, intensive care, pediatrics, and cardiology emphasize a balanced, team approach to heart failure management.
A distinguished list of contributors from some of the major international centers covers this specialty like never before. With recent advances in ultrasound technology and pharmacology the expertise required to care for a critically ill child with heart disease takes an integrated approach with a multidisciplinary team and central focus. This resource provides comprehensive discussions of pertinent cardiac issues in the ICU setting with emphasis on perioperative care.